Xponance, Inc. Vertex Pharmaceuticals Inc Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Xponance, Inc. holds 47,968 shares of VRTX stock, worth $19.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

47,968

Previous 47,695 0.57%

Holding current value

$19.6 Million

Previous $22.4 Million 0.21%

% of portfolio

0.22%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $125,580 - $138,077	273 Added 0.57%	47,968 $22.3 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $4.47 Million - $5.52 Million	-11,371 Reduced 19.25%	47,695 $22.4 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $168,375 - $184,231	413 Added 0.7%	59,066 $24.7 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $192,766 - $230,802	562 Added 0.97%	58,653 $23.9 Million
Q3 2023 Oct 23, 2023	BUY	$338.18 - $362.46 $233,006 - $249,734	689 Added 1.2%	58,091 $20.2 Million
Q2 2023 Jul 13, 2023	SELL	$314.42 - $351.91 $21,694 - $24,281	-69 Reduced 0.12%	57,402 $20.2 Million
Q1 2023 Apr 17, 2023	BUY	$283.23 - $323.1 $376,979 - $430,046	1,331 Added 2.37%	57,471 $18.1 Million
Q4 2022 Jan 23, 2023	BUY	$285.76 - $321.48 $1.39 Million - $1.57 Million	4,870 Added 9.5%	56,140 $0
Q3 2022 Oct 24, 2022	BUY	$273.83 - $305.53 $1.03 Million - $1.15 Million	3,772 Added 7.94%	51,270 $14.8 Million
Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $4.75 Million - $5.91 Million	20,198 Added 73.99%	47,498 $13.4 Million
Q1 2022 Apr 20, 2022	BUY	$221.42 - $260.97 $118,016 - $139,097	533 Added 1.99%	27,300 $7.12 Million
Q4 2021 Jan 31, 2022	BUY	$177.01 - $223.45 $544,836 - $687,779	3,078 Added 12.99%	26,767 $5.88 Million
Q3 2021 Nov 05, 2021	SELL	$181.39 - $202.99 $222,384 - $248,865	-1,226 Reduced 4.92%	23,689 $4.3 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $2.48 Million - $2.93 Million	-13,243 Reduced 34.71%	24,915 $5.02 Million
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $19,252 - $22,441	-93 Reduced 0.24%	38,158 $8.2 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $173,060 - $230,811	836 Added 2.23%	38,251 $9.04 Million
Q3 2020 Oct 26, 2020	BUY	$255.65 - $303.1 $5,624 - $6,668	22 Added 0.06%	37,415 $10.2 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $8.43 Million - $11.1 Million	37,393 New	37,393 $10.9 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account